Addus HomeCare Corporation $ADUS Stake Lifted by Renaissance Group LLC

Renaissance Group LLC boosted its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 31.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,197 shares of the company's stock after buying an additional 13,862 shares during the period. Renaissance Group LLC owned 0.32% of Addus HomeCare worth $6,704,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nordea Investment Management AB lifted its position in Addus HomeCare by 0.3% in the 2nd quarter. Nordea Investment Management AB now owns 36,159 shares of the company's stock valued at $4,131,000 after purchasing an additional 111 shares during the last quarter. Maryland State Retirement & Pension System increased its stake in shares of Addus HomeCare by 1.9% in the second quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company's stock valued at $615,000 after purchasing an additional 101 shares during the period. Harbor Capital Advisors Inc. raised its holdings in shares of Addus HomeCare by 4.5% during the second quarter. Harbor Capital Advisors Inc. now owns 67,219 shares of the company's stock valued at $7,743,000 after buying an additional 2,906 shares during the last quarter. Strs Ohio acquired a new position in shares of Addus HomeCare during the first quarter worth approximately $653,000. Finally, Premier Fund Managers Ltd acquired a new position in shares of Addus HomeCare during the first quarter worth approximately $726,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Trading Down 0.1%

Addus HomeCare stock opened at $107.65 on Wednesday. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $136.72. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market capitalization of $1.99 billion, a price-to-earnings ratio of 23.76, a P/E/G ratio of 1.87 and a beta of 0.88. The company has a 50 day moving average price of $114.91 and a 200 day moving average price of $113.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.53 by $0.03. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company had revenue of $362.30 million during the quarter, compared to analyst estimates of $354.48 million. During the same quarter in the prior year, the company earned $1.30 earnings per share. The company's revenue for the quarter was up 25.0% on a year-over-year basis. Research analysts forecast that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on ADUS shares. UBS Group began coverage on Addus HomeCare in a research report on Tuesday, September 2nd. They set a "buy" rating and a $145.00 price target for the company. Cowen reaffirmed a "buy" rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an "outperform" rating in a research note on Friday, November 7th. Stephens reaffirmed an "overweight" rating and issued a $140.00 price target on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Finally, Barclays increased their price objective on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an "underweight" rating in a report on Tuesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $137.11.

Check Out Our Latest Research Report on Addus HomeCare

Insider Buying and Selling

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the firm's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the sale, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.50% of the company's stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

• Five stocks we like better than Addus HomeCare
• Mastering Discipline: Overcoming Emotional Challenges In Trading
• Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
• The Most Important Warren Buffett Stock for Investors: His Own
• What’s on the Thanksgiving Table? A Stock Pick for Every Course
• Financial Services Stocks Investing
• Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here